Fundraising FoxP53 Invest — Full Portfolio
12 tracked investments · listed companies and verified rows first
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)
Co-investorsAble PartnersAlpha Wave GlobalAtaiBeckleyBailey Venture PartnersBright Success CapitalCatalio Capital Management, LP+12 more
Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function.
BiotechDeep TechHealthtechLongevityAarhus, DK
Simon Mølgaard(Co-founder & CEO)inAnders Dalby(Co-founder)inMathias Ollendorff(Co-founder)inSimon Glerup(Co-founder)in
Co-investorsIndustrifondenInnovestorSound BioventuresSunstone Capital
Aldente is a Norwegian agency that co-creates strategy, communication, and solutions with a focus on sustainability.
Impact & Social GoodMarketing Tech
Co-investors500 Global
Completed patient enrollment in its Phase 2 AURORA trial.
Co-investorsSarsia Management ASForbionInvestinor
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)in
Co-investorsCatalio Capital Management, LPKorify CapitalManta International Consultancy S.A.L
Nykode Therapeutics is a biotechnology company; this investor relations page provides shareholder information, financial reports, and corporate governance details but does not describe the company's specific products or therapeutic focus.
BiotechHealthtechMedical DevicesOslo, NO
Serenatis Bio develops small-molecule drugs targeting glutamate and dopamine pathways to treat obsessive-compulsive disorder, a mental health condition with limited effective therapeutic options.
BiotechMental HealthCambridge, GB
Nick Sireau(Executive Chairman & Co-founder)inDavid Cavalla(CEO & Co-founder)in
Co-investorsZinc
Tom Haga is a photography and film studio offering commercial imagery across categories including hotels, branding, interiors, products, portraits, food and restaurants, aquaculture, industrial, and cars.
Creator EconomyMedia & Entertainment
Tom Haga
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Founder)inIrsyad Khairil(Founder)in
Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesRV Invest GmbHSynBioVen+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Arxx Therapeuticsatai Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.